Literature DB >> 28552021

Maternal copeptin levels in intrahepatic cholestasis of pregnancy.

Ahmet Tayyar1, Ilkbal Temel Yuksel2, Nadiye Koroglu2, Ahter Tanay Tayyar3, Ebru Alici Davutoglu4, Asuman Akkaya Firat5, Berna Aslan Cetin2.   

Abstract

PURPOSE: To investigate the copeptin levels in women with intrahepatic cholestasis of pregnancy (ICP) compared to women with uncomplicated pregnancies.
MATERIALS AND METHODS: This cross-sectional study was conducted in 40 pregnant women with ICP and 38 randomly selected healthy pregnant women, who formed the control group. Serum copeptin concentrations were measured using an enzyme-linked immunosorbent assay.
RESULTS: Maternal age, body mass index at assessment, and gestational age at blood sampling were similar between the two groups. Duration of pregnancy was shorter and mean birth weight was significantly lower in the ICP group compared to the control group. Total bile acid, alanine aminotransferase, aspartate aminotransferase, and gamma glutamyl transferase levels were significantly higher in the ICP group than in the control group. There was no significant difference in copeptin concentrations (2.54 (2.05) versus 2.43 (1.98) ng/ml; p = .5).
CONCLUSIONS: Serum copeptin concentrations did not vary between the pregnancies complicated by ICP and the healthy pregnancy control group.

Entities:  

Keywords:  Copeptin; arginine vasopressin; bile acid; bile physiology; intrahepatic cholestasis

Mesh:

Substances:

Year:  2017        PMID: 28552021     DOI: 10.1080/14767058.2017.1335708

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  Evaluation of FGF-19 and β-klotho as biomarkers in patients with intrahepatic cholestasis of pregnancy.

Authors:  Ahter Tanay Tayyar; Ahmet Tayyar; Sukran Kozali; Resul Karakus; Nadiye Koroglu; Ilkbal Temel Yuksel; Gonca Yetkin Yildirim; Ismail Dag; Mustafa Eroglu
Journal:  Arch Med Sci       Date:  2018-01-10       Impact factor: 3.318

2.  Could first- and second-trimester biochemical markers for Down syndrome have a role in predicting intrahepatic cholestasis of pregnancy?

Authors:  Ahter Tanay Tayyar; Ahmet Tayyar; Tolga Atakul; Cigdem Abide Yayla; Cetin Kilicci; Ahmet Eser; Resul Karakus; Dilsat Herkiloglu; Cevat Rifat Cundubey; Mehmet Tayyar
Journal:  Arch Med Sci       Date:  2017-09-05       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.